Prebeta-1 HDL and coronary heart disease

Current Opinion in Lipidology

Volumn 23, Issue 4, 2012, Pages 367-371

  Kane, John P ^a   Malloy, Mary J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

coronary artery disease; myocardial infarction; prebeta 1 HDL; reverse cholesterol transport

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; PREBETA 1 HIGH DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL TRANSPORT; DISEASE MARKER; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

BIOLOGICAL TRANSPORT; CHOLESTEROL; CORONARY DISEASE; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HUMANS;

EID: 84863984491     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e328353eef1     Document Type: Review

References (22)

1. Wang X, Rader DJ. Molecular regulation of macrophage reverse cholesterol transport. Curr Opin Cardiol 2007; 22:368-372.
2. Kunitake ST, Kane JP. Factors affecting the integrity of high density lipoproteins in the ultracentrifuge. J Lipid Res 1982; 23:936-940.
3. McVicar JP, Kunitake ST, Hamilton RL, Kane JP. Characteristics of human lipoproteins isolated by selected affinity immunosorption of apolipoprotein A-I. Proc Natl Acad Sci USA 1984; 81:1356-1360.
4. Kunitake ST, La Sala KJ, Kane JP. Apoprotein A-I-containing lipoproteins with prebeta electrophoretic mobility. J Lipid Res 1985; 26:549-553.
5. Kunitake ST, Chen GC, Kung SF, et al. Prebeta HDL: unique disposition of apolipoprotein A-I increases susceptibility to proteolysis. Arteriosclerosis 1990; 10:25-30.
6. Fielding PE, Kawano M, Catapano AL, et al. Unique epitope of aplipolipoprotein A-1 expressed in prebeta-1 high density lipoprotein and its role in the catalysed efflux of cellular cholesterol. Biochemistry 1994; 33:6081-6985.
7. Kunitake ST, Mendel CM, Hennessy LK. Interconversion between apolipoprotein A-I-containing lipoproteins of prebeta and alpha electrophoretic mobilities. J Lipid Res 1992; 33:1807-1816.
8. Liadiki KN, Liu T, Xu S, et al. Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor Class B Type I. J Biol Chem 2000; 275:21262-21271.
9. Nakamura Y, Kotite L, Gan Y, et al. Molecular mechanism of reverse cholesterol transport: reaction of preß-migrating high-density lipoprotein with plasma lecithin-cholesterol acyltransferase. Biochemistry 2004; 43:14811-14820.
10. Chau P, Nakamura Y, Fielding CJ, Fielding PE. Mechanism of Prebeta HDL formation and activation. Biochemistry 2006; 45:3981-3987.
11. Cavelier C, Ohnsorg PM, Rohrer L, von Eckardstein A. The ß-chain of cell surface F(O)F(1) ATPase modulates apoA-1 and HDL transcytosis through aortic endothelial cells. Arterioscler Thromb Vasc Biol 2012; 32:131-139.
12. de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, et al. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol 2010; 30:796-801.
13. O'Connor PM, Naya-Vigne JM, Duchateau PN, et al. Measurement of prebetal HDL in human plasma by an ultrafiltration-isotope dilution technique. Anal Biochem 1997; 251:234-240.
14. Sethi A.A., Sampson M., Warnick R. et al. High preß1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol. Clin Chem 2010; 56: 1128-1137.
15. Azstalos BF, Cupples A, Demissie S, et al. High density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants in the Framingham offspring study. Arterioscler Thromb Vasc Biol 2004; 24:2181-2187.
16. O'Connor PM, Zysow BR, Schoenhaus SA, et al. Prebeta-1 HDL in plasma of normolipidemic individuals: influences of plasma lipoproteins, age and gender. J Lipid Res 1998; 39:670-678.
17. Watanabe H, Soderlund S, Soro-Paavonen A, et al. Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness. Arterioscler Thromb Vasc Biol 2008; 26:897-902.
18. Asztalos BF, Collins D, Cupples A, et al. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol 2005; 25:2165-2191.
19. Guey LT, Pullinger CR, Ishida BY, et al. Relation of increased prebeta-1 high density lipoprotein levels to risk of coronary heart disease. Am J Cardiol 2011; 108:360-366.
20. de Vries R, Perton FG, van Tol A, Dullaart RPF. Carotid intima media thickness is related positively to plasma pre ß-high density lipoproteins in nondiabetic subjects. Clinica Chimica Acta 2012; 413:473-477.
21. Hirayama S, Miida T, Miyazaki O, Aizawa Y. Preß1-HDL concentration is a predictor of carotid atherosclerosis in type 2 diabetic patients. Diabetes Care 2007; 30:1289-1991.
22. Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011; 364:127-135.